Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Obsessive Compulsive Disorder (ocd) Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

100 recruiting trials for Obsessive Compulsive Disorder (ocd). Eligibility criteria explained in plain English.

TrialFinderData lists 100 Obsessive Compulsive Disorder (ocd) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 2 is the largest group at 43% (6 studies); the largest phase groups are Phase 2: 6, Phase 1: 3, Phase 3: 2, Phase 1 / Phase 2: 2.

Research is led by Shanghai Mental Health Center (5), Yale University (5), Mclean Hospital (3), among the most active sponsors registered for these trials.

The most frequently studied intervention is deep brain stimulation (device, 5 trials), followed by Repetitive Transcranial Magnetic Stimulation (rTMS), Ketamine.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
2
Phase 3 Trials
10
Sponsors

Track Obsessive Compulsive Disorder (ocd) trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05240924

ERP to Improve Functioning in Veterans With OCD

Obsessive compulsive disorder (OCD) is a debilitating psychiatric illness impacting work, social, and family functioning. Exposure and Response Prevention (ERP) is the sole...

Sponsor: VA Office of Research and DevelopmentEnrolling: 16019 locations
RECRUITINGNCT01635569

Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications...

Sponsor: University of British ColumbiaEnrolling: 1801 location
RECRUITINGNCT06346301

Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.

The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD)....

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 361 location
RECRUITINGNCT05467683

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a...

Sponsor: Jasper A. SmitsEnrolling: 6002 locations
RECRUITINGNCT04730011

Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from...

Sponsor: Susanne WalitzaEnrolling: 1001 location
RECRUITINGNCT04631042

Developing Brain, Impulsivity and Compulsivity

Background: Impulsivity is acting 'without thinking.' Compulsivity is being overly inflexible. People vary in how impulsive or compulsive they are. Extreme versions of these...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 11001 location
RECRUITINGNCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD). These...

Sponsor: Mark NiciuEnrolling: 10001 location
RECRUITINGNCT07031544

Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive...

The goal of this clinical trial is to evaluate the efficacy and influencing factors of the combination of the anterior limb of internal capsule and nucleus accumbens (ALIC-NAc)...

Sponsor: Shanghai Mental Health CenterEnrolling: 6010 locations
RECRUITINGPhase 1NCT07113665

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid...

The goal of this clinical trial is to evaluate the safety and initial clinical effectiveness of MRI-guided focused ultrasound (MRgFUS) thermal ablation (capsulotomy) in patients...

Sponsor: Sunnybrook Health Sciences CentreEnrolling: 101 location
RECRUITINGPhase 3NCT03588975

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

The objective of this study is to compare the efficacy and safety of MACI® vs arthroscopic microfracture in the treatment of participants aged 10 to 17 years with symptomatic...

Sponsor: Vericel CorporationEnrolling: 4512 locations
RECRUITINGNCT06929533

Pharmacogenomics-Supported Psychotropic Prescribing Trial

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

Sponsor: University of ManitobaEnrolling: 2002 locations
RECRUITINGNCT06585618

A Multicenter Pediatric Deep Brain Stimulation Registry

There is limited data on outcomes for children who have undergone deep brain stimulation (DBS) for movement disorders, and individual centers performing this surgery often lack...

Sponsor: Boston Children's HospitalEnrolling: 1001 location
RECRUITINGNCT00575081

Physiological Brain Atlas Development

The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data...

Sponsor: Vanderbilt University Medical CenterEnrolling: 50001 location
RECRUITINGNCT06942559

Brain-Oscillation Synchronized Stimulation of the DMPFC

This trial aims to obtain initial evidence about the clinical efficacy and modulation of neurophysiological markers in obsessive compulsive disorder (OCD) using personalized...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 481 location
RECRUITINGNCT06782867

RNS for Treatment-resistant Obsessive-compulsive Disorder

The purpose of this study is to investigate the effect of personalized responsive neurostimulation (RNS) therapy guided by stereoelectroencephalography (SEEG) in patients with...

Sponsor: Xuanwu Hospital, BeijingEnrolling: 101 location
RECRUITINGNCT06763081

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

The purpose of this study is to identify and validate a panel of genetic markers associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioural activation in...

Sponsor: University of ManitobaEnrolling: 1602 locations
RECRUITINGNCT05994053

Neuromodulation for a Novel OCD Biomarker and Treatment

Although multiple treatments for OCD exist, slow symptom decrease, high remission, and significant side effects for some OCD patients limit their efficacy. More research into the...

Sponsor: Boston University Charles River CampusEnrolling: 901 location
RECRUITINGNCT06102941

Cognitive Control Targets for the Treatment of Obsessive Compulsive Disorder in Young Children

This study aims to examine the effects of a game-like program called cognitive control training (CT) for children with obsessive compulsive disorder (OCD). Children enrolled in...

Sponsor: Columbia UniversityEnrolling: 601 location
RECRUITINGNCT05712057

Neurostimulation Versus Therapy for Problems With Emotions

The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with...

Sponsor: Duke UniversityEnrolling: 2401 location
RECRUITINGNCT06443125

Study on Therapeutic Mechanism of Natural Psychotherapy for Neurosis

explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

Sponsor: Xiang Yang ZhangEnrolling: 502 locations
RECRUITINGNCT07198594

Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder

The goal of this clinical trial is to learn if individualized accelerated repetitive transcranial magnetic stimulation (rTMS) targeting the inferior frontal cortex combined with...

Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji UniversityEnrolling: 201 location
RECRUITINGNCT05359562

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

Studies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for...

Sponsor: University of PennsylvaniaEnrolling: 1202 locations
RECRUITINGNCT06173752

Mechanisms of Exposure Therapy for OCD

Exposure therapy is the most effective treatment available for obsessive compulsive disorder, yet up to 50% of patients do not recover because the mechanisms underlying successful...

Sponsor: Mclean HospitalEnrolling: 4002 locations
RECRUITINGNCT07255131

The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program

An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association....

Sponsor: Rakitzi, StavroulaEnrolling: 521 location
RECRUITINGNCT06804525

LHC-CIDI-5 in Hong Kong

The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use...

Sponsor: The University of Hong KongEnrolling: 25001 location
RECRUITINGNCT05377125

Neural Mechanisms of Response Inhibition Training for OCRD

The impaired ability to suppress an inappropriate but pre-potent response (response inhibition; RI) characterizes several debilitating clinical problems, including...

Sponsor: University of Wisconsin, MilwaukeeEnrolling: 1181 location
RECRUITINGNCT07558148

OCD LIFU Target Engagement

The investigators will conduct a pilot study to evaluate the safety and feasibility of low-intensity focused ultrasound on obsessive-compulsive disorder (OCD) symptoms when...

Sponsor: University of PennsylvaniaEnrolling: 101 location
RECRUITINGNCT02773082

DBS for Obsessive-Compulsive Disorder

There are two primary approaches to the treatment of OCD, pharmacotherapy and cognitive behavior therapy (CBT). Lack of therapeutic success with one approach leads to trials of...

Sponsor: Northwell HealthEnrolling: 501 location
RECRUITINGNCT05577585

Ketamine in OCD: Efficacy and Effects on Stress and Cognition

The main goal of this trial is to demonstrate therapeutic efficacy of low dose ketamine in patients with OCD. We expect that ketamine will alleviate symptoms in the hours...

Sponsor: Medical University of ViennaEnrolling: 601 location
RECRUITINGNCT05048251

Individually Targeted Neuromodulation for Contamination-based OCD

Patients with obsessive-compulsive disorder (OCD) experience a wide array of different types of obsessions and compulsions. However, current treatments for OCD employ a "one size...

Sponsor: Mclean HospitalEnrolling: 501 location
RECRUITINGNCT02537795

Psychiatric Neurosurgery (PNS) for Obsessive Compulsive Disorder (OCD): A Qualitative Analysis of Patient and Family...

In this study the investigators will use semi-structured interviews to qualitatively analyse patient and family member experiences with either deep brain stimulation or other...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 401 location
RECRUITINGNCT07228143

Stepped Care Treatment for Anxiety Resilience

Childhood anxiety disorders (CAD) are common and impairing. Family based cognitive behavioral therapy (CBT) is efficacious in treating CAD. Yet, many children do not receive care...

Sponsor: Andrew WieseEnrolling: 1061 location
RECRUITINGPhase 2NCT05783817

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

The study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).

Sponsor: Carolyn RodriguezEnrolling: 401 location
RECRUITINGNCT06494735

Effect of the French Version If the Metagognitive Bibliotherapy Program "MYMCT" on Obsessive-compulsive Symptoms

Obsessive-compulsive disorder (OCD) is a psychiatric illness characterized by the presence of obsessions and/or compulsions. Without effective treatment, symptoms tend to worsen...

Sponsor: Centre Hospitalier Universitaire de NiceEnrolling: 1141 location
RECRUITINGPhase 2NCT05207085

Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults

This trial aims to evaluate the efficacy, safety and tolerability of valbenazine, titrated to the subject's optimal dose of 40mg or 80mg, administered once daily, for 12 weeks,...

Sponsor: Yale UniversityEnrolling: 201 location
RECRUITINGNCT05160129

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder

Deep brain stimulation (DBS) is an effective treatment for people suffering from severe obsessive-compulsive disorder (OCD) whose symptoms have failed to improve after years and...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 221 location
RECRUITINGPhase 1 / Phase 2NCT06575075

Pilot Study of RR-HNK in OCD

The purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms.

Sponsor: Carolyn RodriguezEnrolling: 451 location
RECRUITINGPhase 2NCT06611592

Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD)

The most common and effective treatment for OCD is pharmacological therapy that includes selective serotonin reuptake inhibitors (SSRIs) antidepressants and, in the case of...

Sponsor: Clinical Academic Center (2CA-Braga)Enrolling: 481 location
RECRUITINGNCT07245134

Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients

The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). Participants are randomly...

Sponsor: National Institute of Mental Health, Czech RepublicEnrolling: 621 location
RECRUITINGPhase 2NCT05940324

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

Sponsor: Stanford UniversityEnrolling: 1501 location
RECRUITINGNCT06582225

ICBT for OCD in Children With Autism

The purpose of this trial is to evaluate the clinical efficacy, the cost-effectiveness and the effect durability of a therapist-guided, internet-delivered cognitive-behavior...

Sponsor: Karolinska InstitutetEnrolling: 2203 locations
RECRUITINGNCT06834217

Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder

Obsessive-compulsive disorder (OCD) is associated with substantial impairments in quality of life and is among the most disabling psychiatric disorders. Exposure therapy is among...

Sponsor: Yale UniversityEnrolling: 1801 location
RECRUITINGNCT05118633

Technology Assisted Treatment for Trichotillomania

The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.

Sponsor: HabitAware Inc.Enrolling: 901 location
RECRUITINGNCT06942494

Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD

The goal of this clinical trial is to learn if self-help book can be used to treat obsessive-compulsive disorder (OCD) in adolescents aged 10 to 17. The main questions it aims to...

Sponsor: Shanghai Mental Health CenterEnrolling: 881 location
RECRUITINGNCT06542224

Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation

Obsessive-compulsive disorder (OCD) is a complex and severe mental illness characterized by multiple symptoms and is considered a leading cause of non-fatal health loss. However,...

Sponsor: West China HospitalEnrolling: 164 locations
RECRUITINGPhase 2NCT04882839

Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD

Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder characterized by recurrent distressing thoughts and substantial anxiety, accompanied by repetitive behaviors or...

Sponsor: Beersheva Mental Health CenterEnrolling: 151 location
RECRUITINGNCT06983301

Brief Cognitive Behaviour Therapy (CBT) for Adolescent OCD in Routine Clinical Practice

Obsessive-Compulsive Disorder (OCD) is a common and often disabling condition in young people, characterised by distressing, intrusive thoughts, images or urges, and repetitive...

Sponsor: University of OxfordEnrolling: 253 locations
RECRUITINGNCT07206212

A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder

The overall aim of this study is to evaluate the efficacy and cost-effectiveness of a lifestyle intervention to improve lifestyle habits and reduce cardiometabolic risk factors in...

Sponsor: Karolinska InstitutetEnrolling: 1081 location
RECRUITINGNCT06050369

Objective Characterizatoion of Repetitive Behaviors

Introduction: Repetitive behaviors (RB) constitute a broad range of symptoms across different psychiatric/neurologic disorders. The most famous are stereotypies (found in...

Sponsor: Institut National de la Santé Et de la Recherche Médicale, FranceEnrolling: 503 locations
RECRUITINGNCT06621381

Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder

The goal of this clinical trial is to evaluate the preliminary outcomes of concentrated exposure and response prevention for children with obsessive-compulsive disorder (OCD) in...

Sponsor: Uppsala University HospitalEnrolling: 201 location

Showing 50 of 100 trials.Search all Obsessive Compulsive Disorder (ocd) trials

Frequently Asked Questions

There are currently 100 clinical trials for Obsessive Compulsive Disorder (ocd), with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Obsessive Compulsive Disorder (ocd), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 2 Phase 3 trials for Obsessive Compulsive Disorder (ocd), representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.